Noncoronary complications of coronary intervention

Catheterization and Cardiovascular Interventions

Volumn 57, Issue 2, 2002, Pages 257-265

  Wiley, Jose M ^a   White, Christopher J ^a   Uretsky, Barry F ^b  

^a OCHSNER CLINIC FOUNDATION   (United States)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

Arteriovenous fistulae; Atheroembolism; Dissection; Hematoma; Nephrotoxicity; Pseudoaneurysm

Indexed keywords

ABCIXIMAB; ACETYLCYSTEINE; ANTIOXIDANT; ANTITHROMBOCYTIC AGENT; COLLAGEN; DIATRIZOATE; DIURETIC AGENT; EPTIFIBATIDE; FENOLDOPAM; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; IOHEXOL; THROMBIN; TIROFIBAN;

ANTICOAGULATION; ARTERIOVENOUS FISTULA; ARTERY CATHETERIZATION; ARTERY DISSECTION; ARTIFICIAL EMBOLISM; BLEEDING; BLOOD TRANSFUSION; BRACHIAL ARTERY; CLINICAL TRIAL; CORONARY ARTERY SURGERY; DRUG HALF LIFE; FALSE ANEURYSM; FEMORAL ARTERY; HEMATOMA; HEMODYNAMICS; HUMAN; KIDNEY DISEASE; LEG ISCHEMIA; NEPHROTOXICITY; NEUROLOGIC DISEASE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; POSTOPERATIVE COMPLICATION; RETROPERITONEAL HEMORRHAGE; REVIEW; RISK FACTOR; SURGICAL TECHNIQUE; SYMPTOMATOLOGY;

ANEURYSM, FALSE; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CONTRAST MEDIA; FEMORAL ARTERY; HEMATOMA; HUMANS; KIDNEY DISEASES; PUNCTURES; RETROPERITONEAL SPACE; THROMBOSIS; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 0036791767     PISSN: 15221946     EISSN: None     Source Type: Journal    
DOI: 10.1002/ccd.10307     Document Type: Review

References (79)

1. Muller DW, Shamir KJ, Ellis SG, Topol EJ. Peripheral vascular complications after conventional and complex percutaneous coronary interventional procedures. Am J Cardiol 1992;69:63-68.
2. Schomig A, Neumann FJ, Kastrati A, Schuhlen H, Blasini R, Hadamitzky M, Walter H, Zitzmann-Roth EM, Richardt G, Alt E, Schmitt C, Ulm K. A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents. N Engl J Med 1996;334:1084-1089.
3. Leon MB, Baim DS, Popma JJ, Gordon PC, Cutlip DE, Ho KK, Giambartolomei A, Diver DJ, Lasorda DM, Williams DO, Pocock SJ, Kuntz RE. A clinical trial comparing three antithromboticdrug regimens after coronary-artery stenting: Stent Anticoagulation Restenosis Study Investigators. N Engl J Med 1998;339:1665-1671.
4. EPILOG investigators. Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization. N Engl J Med 1997;336:1689-1696.
5. Metz D, Meyer P, Touati C, Coste P, Petiteau PY, Durand P, Faivre R, Lefevre T, Elaerts J. Comparison of 6F with 7F and 8F guiding catheters for elective coronary angioplasty: results of a prospective, multicenter, randomized trial. Am Heart J 1997;134:131-137.
6. Aguirre FV, Topol EJ, Ferguson JJ, Anderson K, Blankenship JC, Heuser RR, Sigmon K, Taylor M, Gottlieb R, Hanovich G, et al., for the EPIC investigators. Bleeding complications with the chimeric antibody to platelet glycoprotein IIb/IIIa integrin in patients undergoing percutaneous coronary intervention. Circulation 1995;91:2882-2890.
7. Popma JJ, Satler LF, Pichard AD, Kent KM, Campbell A, Chuang YC, Clark C, Merritt AJ, Bucher TA, Leon MB. Vascular complications after balloon and new device angioplasty. Circulation 1993;88:1569-1578.
8. Waksman R, King SB III, Douglas JS, Shen Y, Ewing H, Mueller L, Ghazzal ZM, Weintraub WS. Predictors of groin complications after balloon and new-device coronary intervention. Am J Cardiol 1995;75:886-889.
9. Friedman HZ, Cragg DR, Glazier SM, Gangadharan V, Marsalese DL, Schreiber TL, O'Neill WW. Randomized prospective evaluation of prolonged versus abbreviated intravenous heparin therapy after coronary angioplasty. J Am Coll Cardiol 1994;24:1214-1219.
10. Rabah M, Mason D, Muller DW, Hundley R, Kugelmass AD, Weiner B, Cannon L, O'Neill WW, Safian RD. Heparin after percutaneous intervention (HAPI): a prospective multicenter randomized trial of three heparin regimens after successful coronary intervention. J Am Coll Cardiol 1999;34:461-467.
11. Mandak JS, Blankenship JC, Gardner LH, Berkowitz SD, Aguirre FV, Sigmon KN, Timmis GC, Gilchrist IC, McIvor M, Resar J, Weiner BH, George BS, Talley JD, Lincoff AM, Tcheng JE, Califf RM, Topol EJ. Modifiable risk factors for vascular access site complications in the IMPACT II trial of angioplasty with versus without eptifibatide: Integrilin to Minimize Platelet Aggregation and Coronary Thrombosis. J Am Coll Cardiol 1998;31:1518-1524.
12. Popma JJ, Satler LF, Pichard AD, Kent KM, Campbell A, Chuang YC, Clark C, Merritt AJ, Bucher TA, Leon MB. Vascular complications after balloon and new device angioplasty. Circulation 1993;88:1569-1578.
13. Lincoff AM, Tcheng JE, Califf RM, Bass T, Popma JJ, Teirstein PS, Kleiman NS, Hattel LJ, Anderson HV, Ferguson JJ, Cabot CF, Anderson KM, Berdan LG, Musco MH, Weisman HF, Topol EJ, for the PROLOG investigators. Standard versus low-dose weight-adjusted heparin in patients treated with the platelet glycoprotein IIb/IIIa receptor antibody fragment abciximab (c7E3 Fab) during percutaneous coronary revascularization. Am J Cardiol 1997;79:286-291.
14. EPILOG investigators. Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization. N Engl J Med 1997;336:1689-1696.
15. Omoigui NA, Califf RM, Pieper K, Keeler G, O'Hanesian MA, Berdan LG, Mark DB, Talley JD, Topol EJ. Peripheral vascular complications in the Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT-1). J Am Coll Cardiol 1995;26:922-930.
16. Johnson LW, Esente P, Giambartolomei A, Grant WD, Loin M, Reger MJ, Shaw C, Walford GD. Peripheral vascular complications of coronary angioplasty by the femoral and brachial techniques. Cathet Cardiovascular Diagn 1994;31:165-172.
17. Sreeram S, Lumsden AB, Miller JS, Salam AA, Dodson TF, Smith RB. Retroperitoneal hematoma following femoral arterial catheterization: a serious and often fatal complication. Am Surg 1993;59:94-98.
18. Kent KC, Moscucci M, Mansour KA, DiMattia S, Gallagher S, Kuntz R, Skillman JJ. Retroperitoneal hematoma after cardiac catheterization: prevalence, risk factors, and optimal management. J Vasc Surg 1994;20:905-913.
19. Shih HC, Wen YS, Ko TJ, Wu JK, Su CH, Lee CH. Noninvasive evaluation of blunt abdominal trauma: prospective study using diagnostic algorithms to minimize nontherapeutic laparotomy. World J Surg 1999;23:265-270.
20. Rothlin MA, Naf R, Amgwerd M, Candinas D, Frick T, Trentz O. Ultrasound in blunt abdominal and thoracic trauma. J Trauma 1993;34:488-495.
21. Kazmers A, Meeker C, Nofz K, Kline R, Groehn H, Oust G, Abson K, Cocking K, Despriet S, Krause M. Nonoperative therapy for postcatheterization femoral artery pseudoaneurysms. Am Surg 1997;63:199-204.
22. Moore DJ, Hilborn MD, Harris KA, Elliott JA, MacDonald AC, Foley JB. Postarteriographic femoral pseudoaneurysms: treatment with ultrasound guided compression. Ann Vasc Surg 1994;8:325-331.
23. Kim D, Orron DE, Skillman JJ, Kent KC, Porter DH, Schlam BW, Carrozza J, Reis GJ, Baim DS. Role of superficial femoral artery puncture in the development of pseudoaneurysm and arteriovenous fistula complicating percutaneous transfemoral cardiac catheterization. Cathet Cardiovasc Diagn 1992;25:91-97.
24. Waksman R, King SB III, Douglas JS, Shen Y, Ewing H, Mueller L, Ghazzal ZM, Weintraub W. Predictors of groin complications after balloon and new-device coronary intervention. Am J Cardiol 1995;75:886-889.
25. Fellineth BD, Baron SB, Brown PR, Ang JG, Clayson KR, Morrisen SL, Low RI. Repair of postcatheterization femoral pseudoaneurysms by color flow ultrasound guided compression. Am Heart J 1992;123:547-551.
26. Feld R, Patton GM, Carabasi RA, Alexander A, Merton D, Needleman L. Treatment of iatrogenic femoral artery injuries with ultrasound-guided compression. J Vasc Surg 1992;16:382-840.
27. Hajarizadeh H, LaRosa CR, Cardullo P, Rohrer MJ, Cutler BS. Ultrasound-guided compression of iatrogenic femoral pseudoaneurysm: failure, recurrence and long-term results. J Vasc Surg 1995;22:425-433.
28. Dean SM, Olin JW, Piedmonte M, Grubb M, Young JR. Ultrasound-guided compression closure of postcatheterization pseudoaneurysm during concurrent anticoagulation: a review of seventyseven patients. J Vasc Surg 1996;23:28-35.
29. Chatterjee T, Do DD, Kaufmann U, Mahler F, Meier B. Ultrasound-guided compression repair for treatment of femoral artery pseudoaneurysm: acute and follow-up results. Cathet Cardiovasc Diagn 1996;38:335-340.
30. Schaub F, Theiss W, Busch R, Heinz M, Paschalidis M, Schomig A. Management of 219 consecutive cases of postcatheterization pseudoaneurysm. J Am Coll Cardiol 1997;30:670-675.
31. Liau C, Ho F, Chen M, Lee Y. Treatment of iatrogenic femoral artery pseudoaneurysm with percutaneous thrombin injection. J Vasc Surg 1997;26:18-23.
32. Kang SS, Labropoulos N, Mansour MA, Baker WH. Percutaneous ultrasound guided thrombin injection: a new method for treating postcatheterization femoral pseudoaneurysms. J Vasc Surg 1998;27:1032-1038.
33. Brophy DP, Sheiman RG, Amatulle P, Akbari CM. Iatrogenic femoral pseudoaneurysms: thrombin injection after failed US-guided compression. Radiology 2000;214:278-282.
34. Kang SS, Labropoulos N, Mansour MA, Michelini M, Filliung D, Baubly MP, Baker WH. Expanded indications for ultrasound-guided thrombin injection of pseudoaneurysms. J Vasc Surg 2000;31:289-298.
35. Paulson Ek, Sheafor DH, Kliewer MA, Nelson RC, Eisenberg LB, Sebastian MW, Sketch MH Jr. Treatment of iatrogenic femoral arterial pseudoaneurysms: comparison of US-guided thrombin injection with compression repair. Radiology 2000;215:403-408.
36. La Perna L, Olin JW, Goines D, Childs MB, Ouriel K. Ultrasound-guided thrombin injection for the treatment of postcatheterization pseudoaneurysms. Circulation 2000;102:2391-2395.
37. McNeil NL, Clark TW. Sonographically guided percutaneous thrombin injection versus sonographically guided compression for femoral artery pseudoaneurysms. Am J Roentgenol 2001;176:459-462.
38. Pezzullo JA, Dupuy DE, Cronan JJ. Percutaneous injection for thrombin for the treatment of pseudoaneurysms after catheterization: an alternative to sonographic guided compression. Am J Roentgenol 2000;175:1035-1040.
39. Cope C, Zeit R. Coagulation of aneurysms by direct percutaneous thrombin injection. Am J Roentgenol 1986;147:383-387.
40. Samal AK, White CJ, Collins TJ, Ramee SR, Jenkins JS. Treatment of femoral artery pseudoaneurysm with percutaneous thrombin injection. Cathet Cardiovasc Intervent 2001;53:259-263.
41. AHFS drug information. Hemostatics 1997;20:12-16.
42. Dorion RP, Hamati HF, Landis B, Frey C, Heydt D, Carey D. Risk and clinical significance of developing antibodies induced by topical thrombin preparations. Arch Pathol Lab Med 1998;122:887-894.
43. Pope M, Johnston KW. Anaphylaxis after thrombin injection of a femoral pseudoaneurysm: recommendations for prevention. J Vasc Surg 2000;32:190-191.
44. Hamraoui K, Ernst SM, van Dessel PF, Kelder JC, ten Berg JM, Suttorp MJ, Jaarsma W, Plokker TH. Efficacy. and safety of percutaneous treatment of iatrogenic femoral artery pseudoaneurysm by biodegradable collagen injection. J Am Coll Cardiol 2002;39:1297-1304.
45. Waigand J, Uhlich F, Gross CM, Thalhammer C, Dietz R. Percutaneous treatment of pseudoaneurysms and arteriovenous fistulas after invasive vascular procedures. Cathet Cardiovasc Intervent 1999;47:157-164.
46. Thalhammer C, Kirchherr AS, Uhlich F, Waigand J, Gross CM. Postcatheterization pseudoaneurysms and arteriovenous fistulas: repair with percutaneous implantation of endovascular covered stents. Radiology 2000;214:127-131.
47. Murray A, Buckenham TM, Belli AM. Direct puncture coil embolization of iatrogenic pseudoaneurysms. J Intervent Radiol 1994;9:183-186.
48. Johnson LW, Esente P, Giambartolomei A, Grant WD, Loin M, Reger MJ, Shaw C, Walford GD. Peripheral vascular complications of coronary angioplasty by the femoral and brachial techniques. Cathet Cardiovasc Diagn 1994;31:165-172.
49. Uhlich F, Gross M, Willenbrock R, Dietz R. Successful percutaneous closure of an arteriovenous fistula with a covered stent. J Invas Cardiol 1995;7:28A.
50. Lemaire JM, Dondelinger RF. Percutaneous coil embolization of iatrogenic pseudoaneurysms. Eur J Radiol 1994;18:96-100.
51. Matsi PJ, Manninen HI. Complications of lower-limb percutaneous transluminal angioplasty: a prospective analysis of 410 procedures on 295 consecutive patients. Cardiovasc Intervent Radiol 1998;21:361-366.
52. Dacie JE, Goldin J. The value of interventional techniques in the management of symptomatic leg ischaemia complicating transfemoral cardiac procedures. Clin Radiol 1994;49:779-783.
53. Manke C, Geissler A, Seitz J, Lenhart M, Kasprzak P, Gmeinwieser J, Feuerbach S. Temporary strecker stent for management of acute dissection in popliteal and crural arteries. Cardiovasc Intervent Radiol 1999;22:141-143.
54. Jahnke T, Voshage G, Muller-Hulsbeck S, Grimm J, Heller M, Brossmann J. Endovascular placement of self-expanding nitinol coil stents for the treatment of femoropopliteal obstructive disease. J Vasc Intervent Radiol 2002;13:257-266.
55. Samore MH, Wessolossky MA, Lewis SM, Shubrooks SJ Jr, Karchmer AW. Frequency, risk factors, and outcome for bacteremia after percutaneous transluminal coronary angioplasty. Am J Cardiol 1997;79:873-877.
56. McCready RA, Siderys H, Pittman JN, Herod GT, Halbrook HG, Fehrenbacher JW, Beckman DJ, Hormuth DA. Septic complications after cardiac catheterization and percutaneous transluminal coronary angioplasty. J Vasc Surg 1991;14:170-174.
57. Kiemeneij F, Laarman GJ, Odekerken D, Slagboom T, van der Wieken R. A randomized comparison of percutaneous transluminal coronary angioplasty by the radial, brachial and femoral approaches: the ACCESS study. J Am Coll Cardiol 1997;29:1269-1275.
58. Stella PR, Kiemeneij F, Laarman GJ, Odekerken D, Slagboom T, Van der Wieken R. Incidence and outcome of radial artery occlusion following transradial artery coronary angioplasty. Cathet Cardiovasc Diagn 1997;40:156-158.
59. Chossat R, Black A, Bossi I, Fajadet J, Marco J. Vascular complications and clinical outcome after coronary angioplasty with platelet IIb/IIIa receptor blockade: comparison of transradial vs. transfemoral arterial access. Eur Heart J 2000;21:662-667.
60. Taguchi H, Kawarabayashi T, Tanaka A, Nishida Y, Sakamoto T, Tahara A, Shimada K, Yoshikawa J. Efficacy and safety of PTCA using brachial approach and low-dose heparin. Cathet Cardiovasc Intervent 2001;54:165-168.
61. Eidt JF, Habibipour S, Saucedo JF, McKee J, Southern F, Barone GW, Talley JD, Moursi M. Surgical complications from hemostatic puncture closure devices. Am J Surg 1999;178:511-516.
62. Carey D, Martin JR, Moore CA, Valentine MC, Nygaard TW. Complications of femoral artery closure devices. Cathet Cardiovasc Intervent 2001;52:3-8.
63. Fram DB, Giri S, Jamil G, Mitchel JF, Boden WE, Din S, Kiernan FJ. Suture closure of the femoral arteriotomy following invasive cardiac procedures: a detailed analysis of efficacy, complications, and the impact of early ambulation in 1,200 consecutive, unselected cases. Cathet Cardiovasc Intervent 2001;53:163-173.
64. Mooney MR, Ellis SG, Gershony G, Yehyawi KJ, Kummer B, Lowrie M. Immediate sealing of arterial puncture sites after cardiac catheterization and coronary interventions: initial U.S. feasibility trial using the Duett vascular closure device. Cathet Cardiovasc Intervent 2000;50:96-102.
65. Lehmann KG, Heath-Lange SJ, Ferris ST. Randomized comparison of hemostasis techniques after invasive cardiovascular procedures. Am Heart J 1999;138:1118-1125.
66. Chamberlin JR, Lardi AB, McKeever LS, Wang MH, Ramadurai G, Grunenwald P, Towne WP, Grassman ED, Leya FS, Lewis BE, Stein LH. Use of vascular sealing devices (VasoSeal and Perclose) versus assisted manual compression (Femostop) in transcatheter coronary interventions requiring abciximab (ReoPro). Cathet Cardiovasc Intervent 1999;47:143-148.
67. Tepel M, Van Der Giet M, Schwarzfeld C, Laufer U, Liermann D, Zidek W. Prevention of radiographic-contrast agent-induced reductions in renal function by acetylcysteine. N Engl J Med 2000;343:180-184.
68. Davidson CJ, Hlatky M, Morris KG, Pieper K, Skelton TN, Schwab SJ, Bashore TM. Cardiovascular and renal toxicity of a nonionic radiographic contrast agent after cardiac catheterization: a prospective trial. Ann Intern Med 1989;110:119-124.
69. Jevnikar AM, Finnie KJ, Dennis B, Plummer DT, Avila A, Linton AL. Nephrotoxicity of high-and-low osmolality contrast media. Nephron 1988;48:300-305.
70. Rudnick M, Goldfarb S, Wexler L, Ludbrook P, Murphy M, Halpern E, Hill J, Winniford M, Cohen M, VanFossen D. Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomized trial. Kid Intl 1995;47:254-261.
71. Weinstein JM, Heyman S, Brevis M. Potential deleterious effects of furosemide in radiocontrast nephropathy. Nephron 1992;62:413-415.
72. Solomon R, Werner C, Mann D, D'Elia J, Silva P. Effects of saline, mannitol and furosemide on acute decreases in renal function induced by radiocontrast agents. N Engl J Med 1994;331:1416.
73. Stevens MA, McCullough PA, Tobin KJ, Speck JP, Westveer DC, Allen DA, Timmis GC, O'Neill WW. A prospective randomized trial of prevention measures in patients at high risk for contrast nephropathy. J Am Coll Cardiol 1999;33:403-411.
74. Bakris GL, Lass NA, Glock D. Renal hemodynamics in radiocontrast medium-induced renal dysfunction: a role for dopamine-I receptors. Kid Int 1999;56:206-210.
75. Gaines PA, Cumberland DC, Kennedy A, Welsh CL, Moorhead P, Rutley MS. Cholesterol embolisation: a lethal complication of vascular catheterisation. Lancet 1988;1:168-170.
76. Rosman HS, Davis TP, Reddy D, Goldstein S. Cholesterol embolization: clinical findings and implications. J Am Coll Cardiol 1990;15:1296-1299.
77. Baim DS, Grossman W. Complications of cardiac catheterization. In: Baim DS, Grossman W, editors. Grossman's cardiac catheterization, angiography, and intervention. Philadelphia: Lippincott Williams and Wilkins; 2000. p 58.
78. Rihal CS, Sutton-Tyrrell K, Guo P, Keller NM, Jandova R, Sellers MA, Schaff HV, Holmes DR Jr. Increased incidence of periprocedural complications among patients with vascular disease undergoing myocardial revascularization Investigation. Circulation 1999;100:171-177.
79. Lanzino G, Fessler RD, Wakhloo AK, Guterman LR, Hopkins LN. Successful intracranial thrombolysis for cerebral thromboembolic complications resulting from cardiovascular diagnostic and interventional procedures. J Invas Cardiol 1999;11:439-443.